RSV Vaccination: New Eligibility for Ages 65–74 with Immunosuppression or Chronic Respiratory Disease (EMIS, SystmOne, AM)
RSV vaccination support will be expanded to include patients aged 65–74 with immunosuppression or chronic respiratory disease, following updated Green Book guidance. All invite and reporting features will be updated across EMIS, S1, and AM systems to ensure these new cohorts are included. The clinical template will also be updated to add an RSV vaccination required box for these groups, ensuring clear identification and streamlined management.